Philippe Moerman Selected Research

Philippe Moerman Research Topics

Disease

27	Neoplasms (Cancer) 05/2018 - 11/2005
10	Endometrial Neoplasms (Endometrial Cancer) 10/2016 - 08/2005
6	Carcinoma (Carcinomatosis) 01/2018 - 12/2008
5	Sarcoma (Soft Tissue Sarcoma) 03/2017 - 12/2004
5	Carcinosarcoma 01/2017 - 12/2004
4	Breast Neoplasms (Breast Cancer) 08/2014 - 01/2008
4	Ovarian Neoplasms (Ovarian Cancer) 09/2013 - 11/2008
3	Endometrial Stromal Sarcoma 03/2017 - 12/2004
3	Adenosarcoma 03/2017 - 03/2003
3	Endometrioid Carcinoma 10/2016 - 12/2008
2	Hydatidiform Mole (Molar Pregnancy) 01/2018 - 08/2016
2	Leiomyosarcoma 03/2017 - 12/2004
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 12/2015
2	Adenocarcinoma 10/2016 - 01/2008
2	Microsatellite Instability 10/2016 - 10/2015
2	Abscess 08/2015 - 11/2006
2	Uterine Neoplasms (Uterine Cancer) 12/2013 - 12/2008
2	Neoplasm Metastasis (Metastasis) 10/2013 - 11/2008
2	Carcinogenesis 12/2008 - 03/2003
2	Adenosarcoma of the uterus 12/2004 - 06/2004
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2018
1	Smooth Muscle Tumor 03/2017
1	Margins of Excision 01/2017
1	Papillary Cystadenoma 10/2016
1	Choriocarcinoma 08/2016
1	Tics (Tic) 08/2016
1	Persistent Fetal Circulation Syndrome 05/2016
1	Aneuploidy (Aneuploid) 09/2015
1	Wounds and Injuries (Trauma) 08/2015
1	Ovarian Epithelial Carcinoma 12/2014
1	Brain Neoplasms (Brain Tumor) 03/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2011
1	Kidney Diseases (Kidney Disease) 01/2011
1	Triple Negative Breast Neoplasms 11/2008
1	Pneumoperitoneum 11/2008
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 10/2008

Drug/Important Bio-Agent (IBA)

6	Progesterone Receptors (Progesterone Receptor)IBA 10/2016 - 06/2004
6	Biological ProductsIBA 12/2009 - 03/2003
4	human ERBB2 proteinIBA 10/2016 - 04/2008
4	PlatinumIBA 12/2014 - 04/2009
4	Estrogen ReceptorsIBA 02/2011 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 03/2017 - 11/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 03/2014
3	Estrogens (Estrogen)FDA Link 10/2016 - 06/2004
3	ParaffinIBA 03/2014 - 12/2008
3	Hormones (Hormone)IBA 12/2006 - 03/2003
2	RNA (Ribonucleic Acid)IBA 01/2017 - 03/2014
2	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 03/2014
2	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 12/2004
2	Messenger RNA (mRNA)IBA 12/2013 - 09/2013
2	Proteins (Proteins, Gene)FDA Link 02/2011 - 04/2009
1	Keratin-20 (Cytokeratin 20)IBA 05/2018
1	Keratin-7 (Cytokeratin 7)IBA 05/2018
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2018
1	Ribosomal Proteins (Ribosomal Protein)IBA 03/2017
1	Ifosfamide FDA LinkGeneric 01/2017
1	Phenobarbital (Luminal)FDA Link 10/2016
1	Trastuzumab (Herceptin)FDA Link 10/2016
1	IGF-I-IGFBP-3 complex FDA Link 10/2016
1	Etoposide (VP 16)FDA LinkGeneric 08/2016
1	Methotrexate (Mexate)FDA LinkGeneric 08/2016
1	Long Noncoding RNAIBA 05/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2015
1	VimentinIBA 10/2015
1	Keratins (Keratin)IBA 10/2015
1	dactolisibIBA 10/2015
1	AZD 6244IBA 10/2015
1	Circulating Tumor DNAIBA 09/2015
1	dichlorobis(azomycin)platinum IIIBA 09/2015
1	Carbon DioxideIBA 08/2015
1	P-2 (P 2)IBA 12/2014
1	Glucose (Dextrose)FDA LinkGeneric 05/2014
1	Formaldehyde (Formol)FDA Link 03/2014
1	VaccinesIBA 12/2013
1	Taxoids (Taxanes)IBA 08/2011
1	TubulinIBA 08/2011
1	StathminIBA 02/2011
1	TOR Serine-Threonine KinasesIBA 02/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2011
1	Imatinib Mesylate (Gleevec)FDA Link 02/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2011
1	Transcription Factors (Transcription Factor)IBA 12/2008
1	Oxygen (Dioxygen)IBA 11/2008

Therapy/Procedure

9	Therapeutics 01/2017 - 11/2006
4	Adjuvant Chemotherapy 02/2013 - 09/2007
3	Neoadjuvant Therapy 01/2017 - 10/2013
2	Drug Therapy (Chemotherapy) 01/2018 - 10/2015
2	Lymph Node Excision (Lymph Node Dissection) 12/2015 - 08/2014
2	Immunotherapy 12/2013 - 09/2013
2	Lasers (Laser) 01/2011 - 04/2009
1	Salpingo-oophorectomy 01/2018
1	Chemoradiotherapy 01/2017
1	Curettage 08/2016
1	Hysterectomy 12/2015
1	Molecular Targeted Therapy 03/2014
1	Laparotomy 11/2008
1	Orchiectomy (Orchidectomy) 10/2008
1	Orchiopexy 10/2008
1	Conservative Treatment 01/2008